Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
Syndax Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 1, 2021
Syndax Pharmaceuticals reported fiscal year 2020 executive compensation information on April 1, 2021.
In 2020, three executives at Syndax Pharmaceuticals received on average a compensation package of $2.4M, a 41% increase compared to previous year.
Average pay of disclosed executives at Syndax Pharmaceuticals
Daphne Karydas, Chief Financial Officer, received $3.1M in total. 91% of Karydas' compensation, or $2.8M, was in option awards. Karydas also received $81K in non-equity incentive plan and $201K in salary.
Briggs W. Morrison, Chief Executive Officer, received a compensation package of $2.2M, which increased by 34% compared to previous year. 59% of the compensation package, or $1.3M, was in option awards.
Michael A. Metzger, Chief Operating Officer, earned $1.9M in 2020, a 28% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 1, 2021.